692 related articles for article (PubMed ID: 31852769)
1. Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study.
El-Salhy M; Hatlebakk JG; Gilja OH; Bråthen Kristoffersen A; Hausken T
Gut; 2020 May; 69(5):859-867. PubMed ID: 31852769
[TBL] [Abstract][Full Text] [Related]
2. Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study.
Halkjær SI; Christensen AH; Lo BZS; Browne PD; Günther S; Hansen LH; Petersen AM
Gut; 2018 Dec; 67(12):2107-2115. PubMed ID: 29980607
[TBL] [Abstract][Full Text] [Related]
3. Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndrome.
Lahtinen P; Jalanka J; Hartikainen A; Mattila E; Hillilä M; Punkkinen J; Koskenpato J; Anttila VJ; Tillonen J; Satokari R; Arkkila P
Aliment Pharmacol Ther; 2020 Jun; 51(12):1321-1331. PubMed ID: 32343000
[TBL] [Abstract][Full Text] [Related]
4. Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial.
Johnsen PH; Hilpüsch F; Cavanagh JP; Leikanger IS; Kolstad C; Valle PC; Goll R
Lancet Gastroenterol Hepatol; 2018 Jan; 3(1):17-24. PubMed ID: 29100842
[TBL] [Abstract][Full Text] [Related]
5. Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial.
Aroniadis OC; Brandt LJ; Oneto C; Feuerstadt P; Sherman A; Wolkoff AW; Kassam Z; Sadovsky RG; Elliott RJ; Budree S; Kim M; Keller MJ
Lancet Gastroenterol Hepatol; 2019 Sep; 4(9):675-685. PubMed ID: 31326345
[TBL] [Abstract][Full Text] [Related]
6. Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial.
Holvoet T; Joossens M; Vázquez-Castellanos JF; Christiaens E; Heyerick L; Boelens J; Verhasselt B; van Vlierberghe H; De Vos M; Raes J; De Looze D
Gastroenterology; 2021 Jan; 160(1):145-157.e8. PubMed ID: 32681922
[TBL] [Abstract][Full Text] [Related]
7. The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation.
Mazzawi T; Lied GA; Sangnes DA; El-Salhy M; Hov JR; Gilja OH; Hatlebakk JG; Hausken T
PLoS One; 2018; 13(11):e0194904. PubMed ID: 30427836
[TBL] [Abstract][Full Text] [Related]
8. Changes in fecal short-chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome.
El-Salhy M; Valeur J; Hausken T; Gunnar Hatlebakk J
Neurogastroenterol Motil; 2021 Feb; 33(2):e13983. PubMed ID: 32945066
[TBL] [Abstract][Full Text] [Related]
9. Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome.
El-Salhy M; Casen C; Valeur J; Hausken T; Hatlebakk JG
World J Gastroenterol; 2021 May; 27(18):2219-2237. PubMed ID: 34025075
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of fecal microbiota transplantation (FMT) in patients with irritable bowel syndrome.
El-Salhy M; Kristoffersen AB; Valeur J; Casen C; Hatlebakk JG; Gilja OH; Hausken T
Neurogastroenterol Motil; 2022 Jan; 34(1):e14200. PubMed ID: 34145677
[TBL] [Abstract][Full Text] [Related]
11. Increasing the Dose and/or Repeating Faecal Microbiota Transplantation (FMT) Increases the Response in Patients with Irritable Bowel Syndrome (IBS).
El-Salhy M; Hausken T; Hatlebakk JG
Nutrients; 2019 Jun; 11(6):. PubMed ID: 31238507
[TBL] [Abstract][Full Text] [Related]
12. The effect of fecal microbiota transplantation on IBS related quality of life and fatigue in moderate to severe non-constipated irritable bowel: Secondary endpoints of a double blind, randomized, placebo-controlled trial.
Johnsen PH; Hilpüsch F; Valle PC; Goll R
EBioMedicine; 2020 Jan; 51():102562. PubMed ID: 31877418
[TBL] [Abstract][Full Text] [Related]
13. Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome.
Mizuno S; Masaoka T; Naganuma M; Kishimoto T; Kitazawa M; Kurokawa S; Nakashima M; Takeshita K; Suda W; Mimura M; Hattori M; Kanai T
Digestion; 2017; 96(1):29-38. PubMed ID: 28628918
[TBL] [Abstract][Full Text] [Related]
14. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
Mazzawi T; Hausken T; Hov JR; Valeur J; Sangnes DA; El-Salhy M; Gilja OH; Hatlebakk JG; Lied GA
Scand J Gastroenterol; 2019 Jun; 54(6):690-699. PubMed ID: 31190584
[No Abstract] [Full Text] [Related]
15. Efficacy of Fecal Microbiota Transplantation for Patients With Irritable Bowel Syndrome at 3 Years After Transplantation.
El-Salhy M; Winkel R; Casen C; Hausken T; Gilja OH; Hatlebakk JG
Gastroenterology; 2022 Oct; 163(4):982-994.e14. PubMed ID: 35709830
[TBL] [Abstract][Full Text] [Related]
16. Effects of fecal microbiota transplantation in subjects with irritable bowel syndrome are mirrored by changes in gut microbiome.
Goll R; Johnsen PH; Hjerde E; Diab J; Valle PC; Hilpusch F; Cavanagh JP
Gut Microbes; 2020 Nov; 12(1):1794263. PubMed ID: 32991818
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
Xu D; Chen VL; Steiner CA; Berinstein JA; Eswaran S; Waljee AK; Higgins PDR; Owyang C
Am J Gastroenterol; 2019 Jul; 114(7):1043-1050. PubMed ID: 30908299
[TBL] [Abstract][Full Text] [Related]
18. Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome.
Ianiro G; Eusebi LH; Black CJ; Gasbarrini A; Cammarota G; Ford AC
Aliment Pharmacol Ther; 2019 Aug; 50(3):240-248. PubMed ID: 31136009
[TBL] [Abstract][Full Text] [Related]
19. The fecal microbiota transplantation response differs between patients with severe and moderate irritable bowel symptoms.
El-Salhy M; Mazzawi T; Hausken T; Hatlebakk JG
Scand J Gastroenterol; 2022 Sep; 57(9):1036-1045. PubMed ID: 35486073
[TBL] [Abstract][Full Text] [Related]
20. Allogenic Faecal Microbiota Transfer Induces Immune-Related Gene Sets in the Colon Mucosa of Patients with Irritable Bowel Syndrome.
Holster S; Hooiveld GJ; Repsilber D; Vos WM; Brummer RJ; König J
Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31597320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]